Expression and prognostic significance of different mRNA 5′‐end variants of the oncogene <i>EVI1</i> in 266 patients with de novo AML: <i>EVI1</i> and <i>MDS1/EVI1</i> overexpression both predict short remission duration
Katja Haas(Medical University of Vienna), Rotraud Wieser(Medical University of Vienna), Cristina Sauerland(University of Münster), Wolf‐Dieter Ludwig(Helios Hospital Berlin-Buch), Harald Esterbauer(Vienna General Hospital), Helga Gruener(Hanusch Hospital), Elisabeth Koller(Hanusch Hospital), Christa Fonatsch(Medical University of Vienna), Wolfgang R. Sperr(Medical University of Vienna), Michael Kundi(Medical University of Vienna), Richard Ratei(Helios Hospital Berlin-Buch), Peter Valent(Medical University of Vienna)
Cited by 56
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589
Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.
|PubMed|2012|531
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496